company background image
540701

Dishman Carbogen Amcis BSE:540701 Stock Report

Last Price

₹83.80

Market Cap

₹12.9b

7D

-1.2%

1Y

-56.7%

Updated

07 Feb, 2023

Data

Company Financials +

Dishman Carbogen Amcis Limited

BSE:540701 Stock Report

Mkt Cap: ₹12.9b

540701 Stock Overview

Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally.

540701 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 45.8% below our estimate of its fair value

Earnings are forecast to grow 89.81% per year

Risk Analysis

No risks detected for 540701 from our risk checks.

My Notes

New

Notes are coming soon

Dishman Carbogen Amcis Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dishman Carbogen Amcis
Historical stock prices
Current Share Price₹83.80
52 Week High₹202.40
52 Week Low₹80.05
Beta1.22
1 Month Change-8.81%
3 Month Change-23.19%
1 Year Change-56.68%
3 Year Change-16.58%
5 Year Change-75.64%
Change since IPO-76.14%

Recent News & Updates

Recent updates

Shareholder Returns

540701IN Life SciencesIN Market
7D-1.2%-13.2%-0.8%
1Y-56.7%-28.3%-2.4%

Return vs Industry: 540701 underperformed the Indian Life Sciences industry which returned -28.3% over the past year.

Return vs Market: 540701 underperformed the Indian Market which returned -2.4% over the past year.

Price Volatility

Is 540701's price volatile compared to industry and market?
540701 volatility
540701 Average Weekly Movement4.1%
Life Sciences Industry Average Movement5.1%
Market Average Movement5.7%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.4%

Stable Share Price: 540701 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 540701's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19831,168Arpit Vyashttps://imdcal.com

Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients.

Dishman Carbogen Amcis Limited Fundamentals Summary

How do Dishman Carbogen Amcis's earnings and revenue compare to its market cap?
540701 fundamental statistics
Market Cap₹12.87b
Earnings (TTM)-₹152.40m
Revenue (TTM)₹22.86b

0.6x

P/S Ratio

-85.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
540701 income statement (TTM)
Revenue₹22.86b
Cost of Revenue₹6.56b
Gross Profit₹16.30b
Other Expenses₹16.45b
Earnings-₹152.40m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 10, 2023

Earnings per share (EPS)-0.97
Gross Margin71.32%
Net Profit Margin-0.67%
Debt/Equity Ratio29.8%

How did 540701 perform over the long term?

See historical performance and comparison